NARA.CN CNQ
Pangenomic Health Inc.
1W: +20.0%
1M: +0.0%
3M: -18.9%
YTD: -43.4%
1Y: -84.9%
3Y: -80.0%
C$0.30 ($0.21)
-0.03 (-7.69%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$590
+99.9% ▲
Operating Income
-$1K
+100.0% ▲
Net Income
-$4K
+99.9% ▲
EPS (Diluted)
$-0.82
-173.3% ▼
EBITDA
-$1K
+100.0% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $2K | $11K | $681K | $590 |
| Gross Profit | $0 | -$2K | -$11K | -$681K | -$590 |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $0 | $130K | $534K | $254K | $18 |
| SG&A Expenses | $137K | $737K | $3M | $2M | $532 |
| Operating Expenses | $137K | $869K | $4M | $2M | $550 |
| Operating Income | -$137K | -$853K | -$4M | -$3M | -$1K |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $3K | $2K | $1K | $44K | $67K |
| Income Before Tax | -$140K | -$3M | -$12M | -$3M | -$4K |
| Tax Expense | -$135 | $2K | $8M | $0 | $0 |
| Net Income | -$140K | -$3M | -$20M | -$3M | -$4K |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-0.24 | $-1.34 | $-2.19 | $-0.30 | $-0.82 |
| EBITDA | -$2K | -$848K | -$4M | -$3M | -$1K |
| Shares Outstanding | 586936 | 2M | 5M | 10M | 4660 |